Where does Roche Molecular Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Roche Molecular Systems, Inc. ranks #1,083 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Roche Molecular Systems, Inc. hold?

Roche Molecular Systems, Inc. holds 395 US utility patents granted between 2015 and 2025, spanning 67 technology areas.

What is Roche Molecular Systems, Inc.'s Innovation Score?

Roche Molecular Systems, Inc. has an Innovation Score of 57.8 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Roche Molecular Systems, Inc.'s patent grant rate increasing or decreasing?

Roche Molecular Systems, Inc.'s recent grant velocity is -19% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Roche Molecular Systems, Inc.'s patents?

Roche Molecular Systems, Inc.'s patents average 11.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Roche Molecular Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Roche Molecular Systems, Inc.

Q: What technology areas does Roche Molecular Systems, Inc. focus on?

Roche Molecular Systems, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 220 patents, ranking #13 of 2,502 assignees active in that subclass. Grants appear in 67 CPC subclasses total.

USPTO PatentsView assignee record - 395 granted patents across 67 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Roche ranks #1,083 of 49,997 tracked US assignees by granted-patent volume, with 395 patents across 67 technology areas.

#1,083
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.8/100): 11.7
avg claims per patent: -19%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1083 · US Corporation #1,083 · 395 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 395 grants
TOP-DECILE #1,083/49,997
PHOTO-FINISH Digital Global Systems
CPC-WIDE C12Q · 67 areas
INNOV-PAR 57.8/100
CLAIMS-PAR 11.7 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -19% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Digital Global Systems, Inc. (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Roche’s 57.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 20.7 pts (36%) Velocity 5.1 pts (9%) Breadth 25.0 pts (43%) Claim depth 7.0 pts (12%)

Qualcomm Incorporated · highest

85
Roche Molecular… · this assignee

58
SHL Medical · near

58
University-industry… · near

58
Valve · near

58
Zoetis Services · near

58
3D Lighting… · lowest

7

What this shows Roche's Innovation Score is 57.8/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Roche?

Each dot is one of Roche’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Roche’s own 11.7 claims/patent is at or below the 17.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Roche vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Roche's grant cadence moved

Between 2020–2024, Roche Molecular Systems, Inc. received 171 grants versus 210 in 2015–2019 (-19% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2018 at 55 grants and bottomed in 2022 at 26. Lead class C12Q accounts for 55.7% of the portfolio across 67 subclasses. Volume neighbours: Mstar Semiconductor, Inc. (#1,079) and Stats ChipPAC Pte. Ltd. (#1,087).

Roche's three-year grant acceleration

From 2019–2021 to 2022–2024, Roche Molecular Systems, Inc. moved from 117 to 89 grants (0.76x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,957. See the growth leaderboard.

Mstar Semiconduct…

399
Solaredge

399
Digital Global Sy…

396
Zynga

396
Roche Molecular S… ◀

395
Mueller Internati…

393
Commscope Connect…

392
Fujitsu Component

392
Stats Chippac Pte

392

What this shows Roche holds 395 patents at rank #1,083, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Roche

By rank, the assignees closest to #1,083 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Roche's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Roche, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Roche ranks #13 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (58 here).

SHL Medical AG 58 University-industry Cooperation Group OF Kyung HEE University 58 Valve Corporation 58 Zoetis Services LLC 58

Similar claim depth

Nearest assignees by average claims per patent (11.7 here).

Shell USA, Inc. 11.7 avg Industry-academia Cooperation Group OF Sejong University 11.7 avg Giga-byte Technology Co., Ltd. 11.7 avg International Engine Intellectual Property Company, LLC 11.7 avg

Roche's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Roche Molecular Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	32	8.1%
2016	54	13.7%
2017	34	8.6%
2018	55	13.9%
2019	35	8.9%
2020	50	12.7%
2021	32	8.1%
2022	26	6.6%
2023	30	7.6%
2024	33	8.4%
2025partial year	14	3.5%

Which technologies does Roche Molecular Systems, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 220

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 116

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 98

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 84

C12Y - Enzymes 60

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 41

Y10T - Technical Subjects Covered BY Former US Classification 18

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 17

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 15

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 12

Y02A - Technologies FOR Adaptation TO Climate Change 11

G06F - Electric Digital Data Processing 11

C07K - Peptides 11

G06T - Image Data Processing OR Generation, IN General 9

B01F - Mixing, e.g. Dissolving, Emulsifying OR Dispersing 8

Top 15 of 67 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Roche Molecular Systems, Inc.'s patent record in context - here's where to go next.

Roche Molecular Systems, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 55.7% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #1,083 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Roche Molecular Systems, Inc. against Mstar Semiconductor, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.